Hvordan kan du forberede din portefølje til resten af 2. kvartal?
- 80
Tidspunktet for de første rentenedsættelser begynder at nærme sig. Alligevel står vi stadig over for usikkerheden om, hvornår de ...
Saxo Bank
Hos Saxo tror vi på, at når du investerer, bliver du nysgerrig på verden omkring dig.
Saxos rejse begyndte i København i 1992. Vi er et internationalt investeringsselskab for investorer der vil have mere ud af deres penge. Vores forretning er bygget på tillid, rimelighed og sikkerhed.
Vi giver investorer adgang til de globale finansielle markeder med vores prisvindende digitale handelsplatforme. Faktisk har vores kunder adgang til flere end 70.000 finansielle instrumenter.
Besøg: www.home.saxo
Lastest news
- Affimed Provides Follow-up Data of AFM24 plus Atezolizumab Showing Durable Responses in Heavily Pretreated NSCLC EGFR Wild-type Patients and Positive Initial Data from the NSCLC EGFR Mutant Cohort
- Prospera Energy Inc. Announces 2023 Financial Results
- WATCH by Aisles: A Revolutionary AI System for Public Safety
- Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
- SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical Update Presented at ASCO 2024
- Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)